Imidocarb Dipropionate Lacks Efficacy Against and Fails to Consistently Clear in Horses Co-Infected with

Overview

Journal Pathogens

Date 2020 Dec 16

PMID 33321715

Citations 14

Authors

Kelly Sears

Donald Knowles

Kelcey Dinkel

Philip W Mshelia

Cynthia Onzere

Marta Silva

Lindsay Fry

Affiliations

Soon will be listed here.

Abstract

Control of , the primary cause of equine theileriosis, is largely reliant on acaracide use and chemosterilization with imidocarb dipropionate (ID). However, it is currently unknown if ID is effective against , the recently identified second causative agent of equine theileriosis, or if the drug maintains effectiveness against in the presence of co-infection. The purpose of this study was to address these questions using ID treatment of the following three groups of horses: (1) five infected horses; (2) three - infected horses; and (3) three - infected horses. Clearance was first evaluated using nPCR for each sp. on peripheral blood samples. ID failed to clear in all three groups of horses, and failed to clear in two of three horses in group two. For definitive confirmation of infection status, horses in groups two and three underwent splenectomy post-treatment. The -nPCR-positive horses in group two developed severe clinical signs and were euthanized. Remaining horses exhibited moderate signs consistent with . Our results demonstrate that ID therapy lacks efficacy against , and - co-infection may interfere with ID clearance of .

Citing Articles

Epidemiology and genetic diversity of Theileria equi and Babesia caballi in draft horses in the Distrito Federal, Brazil.

Fernandes T, Paulino P, Dos Santos Juliano D, Rabello C, de Oliveira N, de Souza Santana M Trop Anim Health Prod. 2025; 57(2):72.

PMID: 39969660 DOI: 10.1007/s11250-025-04321-x.

Molecular Diagnosis and Identification of Equine Piroplasms: Challenges and Insights from a Study in Northern Italy.

Facile V, Magliocca M, Dini F, Imposimato I, Mariella J, Freccero F Animals (Basel). 2025; 15(3).

PMID: 39943207 PMC: 11815923. DOI: 10.3390/ani15030437.

Current vaccines, experimental immunization trials, and new perspectives to control selected vector borne blood parasites of veterinary importance.

Alzan H, Mahmoud M, Suarez C Front Vet Sci. 2024; 11:1484787.

PMID: 39606652 PMC: 11602000. DOI: 10.3389/fvets.2024.1484787.

The Combination of Buparvaquone and ELQ316 Exhibit a Stronger Effect than ELQ316 and Imidocarb Against In Vitro.

Cardillo N, Villarino N, Lacy P, Riscoe M, Doggett J, Ueti M Pharmaceutics. 2024; 16(11).

PMID: 39598526 PMC: 11597495. DOI: 10.3390/pharmaceutics16111402.

New insights in the diagnosis and treatment of equine piroplasmosis: pitfalls, idiosyncrasies, and myths.

Mendoza F, Perez-Ecija A, Kappmeyer L, Suarez C, Bastos R Front Vet Sci. 2024; 11:1459989.

PMID: 39205808 PMC: 11349644. DOI: 10.3389/fvets.2024.1459989.

References

Scoles G, Ueti M . Vector ecology of equine piroplasmosis. Annu Rev Entomol. 2015; 60:561-80. DOI: 10.1146/annurev-ento-010814-021110. View

de Waal D, van Heerden J, van den Berg S, Stegmann G, Potgieter F . Isolation of pure Babesia equi and Babesia caballi organisms in splenectomized horses from endemic areas in South Africa. Onderstepoort J Vet Res. 1988; 55(1):33-5. View

Bowden G, Reis P, Rogers M, Bone Relat R, Brayton K, Wilson S . A conserved coccidian gene is involved in Toxoplasma sensitivity to the anti-apicomplexan compound, tartrolon E. Int J Parasitol Drugs Drug Resist. 2020; 14:1-7. PMC: 7394737. DOI: 10.1016/j.ijpddr.2020.07.003. View

Hines S, Ramsay J, Kappmeyer L, Lau A, Ojo K, Van Voorhis W . Theileria equi isolates vary in susceptibility to imidocarb dipropionate but demonstrate uniform in vitro susceptibility to a bumped kinase inhibitor. Parasit Vectors. 2015; 8:33. PMC: 4311422. DOI: 10.1186/s13071-014-0611-6. View

Wise L, Pelzel-McCluskey A, Mealey R, Knowles D . Equine piroplasmosis. Vet Clin North Am Equine Pract. 2014; 30(3):677-93. DOI: 10.1016/j.cveq.2014.08.008. View

Ambawat H, Malhotra D, Kumar S, Dhar S . Erythrocyte associated haemato-biochemical changes in Babesia equi infection experimentally produced in donkeys. Vet Parasitol. 1999; 85(4):319-24. DOI: 10.1016/s0304-4017(99)00110-7. View

Cunha C, McGuire T, Kappmeyer L, Hines S, Lopez A, Dellagostin O . Development of specific immunoglobulin Ga (IgGa) and IgGb antibodies correlates with control of parasitemia in Babesia equi Infection. Clin Vaccine Immunol. 2006; 13(2):297-300. PMC: 1391941. DOI: 10.1128/CVI.13.2.297-300.2006. View

Kutscha J, Sutton D, Preston T, Guthrie A . Equine piroplasmosis treatment protocols: specific effect on orocaecal transit time as measured by the lactose 13C-ureide breath test. Equine Vet J Suppl. 2013; (43):62-7. DOI: 10.1111/j.2042-3306.2012.00656.x. View

Knowles D, Kappmeyer L, Haney D, Herndon D, Fry L, Munro J . Discovery of a novel species, Theileria haneyi n. sp., infective to equids, highlights exceptional genomic diversity within the genus Theileria: implications for apicomplexan parasite surveillance. Int J Parasitol. 2018; 48(9-10):679-690. DOI: 10.1016/j.ijpara.2018.03.010. View

10.

KUTTLER K, Gipson C, Goff W, Johnson L . Experimental Babesia equi infection in mature horses. Am J Vet Res. 1986; 47(8):1668-70. View

11.

Knowles Jr D, Kappmeyer L, Stiller D, Hennager S, Perryman L . Antibody to a recombinant merozoite protein epitope identifies horses infected with Babesia equi. J Clin Microbiol. 1992; 30(12):3122-6. PMC: 270599. DOI: 10.1128/jcm.30.12.3122-3126.1992. View

12.

Hansen J, Day T . Coinfection and the evolution of drug resistance. J Evol Biol. 2014; 27(12):2595-604. DOI: 10.1111/jeb.12518. View

13.

Adams L . Clinicopathological aspects of imidocarb dipropionate toxicity in horses. Res Vet Sci. 1981; 31(1):54-61. View

14.

Ueti M, Palmer G, Scoles G, Kappmeyer L, Knowles D . Persistently infected horses are reservoirs for intrastadial tick-borne transmission of the apicomplexan parasite Babesia equi. Infect Immun. 2008; 76(8):3525-9. PMC: 2493223. DOI: 10.1128/IAI.00251-08. View

15.

Bishop R, Kappmeyer L, Onzere C, Odongo D, Githaka N, Sears K . Equid infective Theileria cluster in distinct 18S rRNA gene clades comprising multiple taxa with unusually broad mammalian host ranges. Parasit Vectors. 2020; 13(1):261. PMC: 7236219. DOI: 10.1186/s13071-020-04131-0. View

16.

Pasolini M, Pagano T, Costagliola A, De Biase D, Lamagna B, Auletta L . Inflammatory Myopathy in Horses With Chronic Piroplasmosis. Vet Pathol. 2017; 55(1):133-143. DOI: 10.1177/0300985817716262. View

17.

Silva M, Villarino N, Knowles D, Suarez C . Assessment of Draxxin (tulathromycin) as an inhibitor of in vitro growth of Babesia bovis, Babesia bigemina and Theileria equi. Int J Parasitol Drugs Drug Resist. 2018; 8(2):265-270. PMC: 6039354. DOI: 10.1016/j.ijpddr.2018.04.004. View

18.

Sears K, Kappmeyer L, Wise L, Silva M, Ueti M, White S . Infection dynamics of Theileria equi and Theileria haneyi, a newly discovered apicomplexan of the horse. Vet Parasitol. 2019; 271:68-75. DOI: 10.1016/j.vetpar.2019.06.009. View

19.

Bhoora R, Collins N, Schnittger L, Troskie C, Marumo R, Labuschagne K . Molecular genotyping and epidemiology of equine piroplasmids in South Africa. Ticks Tick Borne Dis. 2019; 11(2):101358. DOI: 10.1016/j.ttbdis.2019.101358. View

20.

Grause J, Ueti M, Nelson J, Knowles D, Kappmeyer L, Bunn T . Efficacy of imidocarb dipropionate in eliminating Theileria equi from experimentally infected horses. Vet J. 2012; 196(3):541-6. DOI: 10.1016/j.tvjl.2012.10.025. View